1,329 results on '"Blom, Anna M"'
Search Results
2. Stromal cartilage oligomeric matrix protein as a tumorigenic driver in ovarian cancer via Notch3 signaling and epithelial-to-mesenchymal transition
3. Tumor suppressor role of the complement inhibitor CSMD1 and its role in TNF-induced neuroinflammation in gliomas
4. Intracellular cartilage oligomeric matrix protein augments breast cancer resistance to chemotherapy
5. The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma
6. Pandrug-resistant Klebsiella pneumoniae isolated from Ukrainian war victims are hypervirulent
7. Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular repair responses and angiogenesis
8. CSMD1 regulates brain complement activity and circuit development
9. Elevated expression of complement factor I in lung cancer cells associates with shorter survival–Potentially via non-canonical mechanism
10. A subset of type-II collagen-binding antibodies prevents experimental arthritis by inhibiting FCGR3 signaling in neutrophils
11. Prompt Thrombo-Inflammatory Response to Ischemia-Reperfusion Injury and Kidney Transplant Outcomes
12. C4BP(β-)-mediated immunomodulation attenuates inflammation in DSS-induced murine colitis and in myeloid cells from IBD patients
13. The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML
14. Sushi domain-containing protein 4 binds to epithelial growth factor receptor and initiates autophagy in an EGFR phosphorylation independent manner
15. Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators
16. Intracellular complement and immunometabolism: The advantages of compartmentalization.
17. Alternative translation and retrotranslocation of cytosolic C3 that detects cytoinvasive bacteria
18. A soft tick Ornithodoros moubata salivary protein OmCI is a potent inhibitor to prevent avian complement activation
19. Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy
20. Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators.
21. ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development
22. C3 glomerulopathy — understanding a rare complement-driven renal disease
23. Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular cells
24. Recruitment of C4b-binding protein is not a complement evasion strategy employed by Staphylococcus aureus
25. 27 Elucidating the molecular mechanisms mediating the tumor suppressive actions of complement inhibitor CSMD1 in gliomas
26. 101 CD59 isoforms IRIS-1 and IRIS-2 are expressed in human and mouse brains, required for neurotransmitter release, and have a decreased expression in Alzheimer[StQuote]s disease patient[StQuote]s brains
27. 92 Treatment with warfarin but not Factor Xa inhibitors, is associated with dysregulated, noncanonical, complement activation
28. 71 Acinetobacter baumannii clinical isolates evade complement-mediated lysis by inhibiting the complement cascade and improperly depositing MAC
29. 210 Complement activation in patients with ANCA-associated vasculitis – focusing on complement activation markers in remission
30. 57 Opsonization and efferocytosis of dying cells are modulated by the presence of malondialdehyde epitopes
31. Intracellular C3 protects β-cells from IL-1β-driven cytotoxicity via interaction with Fyn-related kinase.
32. Genetic predisposition to infection in a case of atypical hemolytic uremic syndrome
33. Citrullination of C1-inhibitor as a mechanism of impaired complement regulation in rheumatoid arthritis
34. C4b-binding protein inhibits particulate- and crystalline-induced NLRP3 inflammasome activation
35. Expression of Cartilage Oligomeric Matrix Protein in colorectal cancer is an adverse prognostic factor and correlates negatively with infiltrating immune cells and PD-L1 expression
36. Citrullination of C1-inhibitor as a mechanism of impaired complement regulation in rheumatoid arthritis
37. Complimentary action: C1q increases ganglion cell survival in an in vitro model of retinal degeneration
38. C4b-Binding Protein
39. List of Contributors
40. Factor I
41. Complement activation negatively affects the platelet response to thrombopoietin receptor agonists in patients with immune thrombocytopenia: a prospective cohort study.
42. Neisseria gonorrhoeae co-opts C4b-binding protein to enhance complement-independent survival from neutrophils
43. Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
44. The human serum protein C4b-binding protein inhibits pancreatic IAPP-induced inflammasome activation
45. Neisseria gonorrhoeaeco-opts C4b-binding protein to enhance complement-independent survival from neutrophils
46. The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML
47. Haemophilus influenzae stores and distributes hemin by using Protein E
48. RETRACTION: Dominant suppression of inflammation by glycan-hydrolyzed IgG
49. Viral Heparin-Binding Complement Inhibitors – A Recurring Theme
50. Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.